MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

In this study, we examined the role of the miRNA miR-770-5p in cisplatin chemotherapy resistance in ovarian cancer (OVC) patients. miR-770-5p expression was reduced in platinum-resistant patients. Using a 6.128-fold in expression as the cutoff value, miR-770-5p expression served as a prognostic biom...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Zhao, Henan, Yu, Xiaotang, Ding, Yanfang, Zhao, Jinyao, Wang, Guang, Wu, Xian, Jiang, Jiyong, Peng, Chun, Guo, Gordon Zhuo, Cui, Shiying
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288183/
https://ncbi.nlm.nih.gov/pubmed/27449101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10736
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires